Unknown

Dataset Information

0

Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis.


ABSTRACT:

Rationale

Ivacaftor is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator recently approved for patients with CF age 6 and older with the G551D mutation.

Objectives

To evaluate ivacaftor in a postapproval setting and determine mechanism of action and response of clinically relevant markers.

Methods

We conducted a longitudinal cohort study in 2012-2013 in G551D CF patients age 6 and older with no prior exposure to ivacaftor. Study assessments were performed at baseline, 1, 3, and 6 months after ivacaftor initiation. Substudies evaluated mucociliary clearance, β-adrenergic sweat secretion rate, gastrointestinal pH, and sputum inflammation and microbiology Measurements and Main Results: A total of 151 of 153 subjects were prescribed ivacaftor and 88% completed the study through 6 months. FEV1 % predicted improved from baseline to 6 months (mean absolute change, 6.7%; P < 0.001). Similarly, body mass index improved from baseline to 6 months (mean change, 0.8 kg/m(2); P < 0.001). Sweat chloride decreased from baseline to 6 months (mean change, -53.8 mmol/L; 95% confidence interval, -57.7 to -49.9; P < 0.001), reflecting augmented CFTR function. There was significant improvement in hospitalization rate (P < 0.001) and Pseudomonas aeruginosa burden (P < 0.01). Significant improvements in mucociliary clearance (P < 0.001), gastrointestinal pH (P = 0.001), and microbiome were also observed, providing clinical mechanisms underlying the therapeutic benefit of ivacaftor.

Conclusions

Significant clinical and physiologic improvements were observed on initiation of ivacaftor in a broad patient population, including reduced infection with P. aeruginosa. Biomarker studies substantially improve the understanding of the mechanistic consequences of CFTR modulation on pulmonary and gastrointestinal physiology.

SUBMITTER: Rowe SM 

PROVIDER: S-EPMC4226057 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC5918150 | biostudies-literature
| S-EPMC8935475 | biostudies-literature
| S-EPMC8184517 | biostudies-literature
| S-EPMC7134581 | biostudies-literature
2006-03-24 | GSE4513 | GEO
| S-EPMC3552343 | biostudies-literature
| S-EPMC4390299 | biostudies-literature
| S-EPMC4159205 | biostudies-other
| S-EPMC3277286 | biostudies-literature
| S-EPMC5036583 | biostudies-literature